Lanean...
Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive Disorder
Major depressive disorder (MDD) contributes to a significant worldwide disease burden, expected to be second only to heart disease by 2050. However, accurate diagnosis has been a historical weakness in clinical psychiatry. As a result, there is a demand for diagnostic modalities with greater objecti...
Gorde:
| Argitaratua izan da: | Front Psychiatry |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Frontiers Media S.A.
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4843170/ https://ncbi.nlm.nih.gov/pubmed/27199779 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fpsyt.2016.00072 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|